Featured Articles

• 

  Corrigendum to: Diagnosis and management of acute deep vein thrombosis: a joint consensus document ...

  Eur Heart J 2017; DOI: 10.1093/eurheartj/ehx003] ... The authors wish to inform readers that the Conflict of Interest statement was incorrect as first published. The statement should have been ...

  Saturday, April 14th 2018

• 

  Corrigendum to: Diagnosis and management of acute deep vein thrombosis: a joint consensus document ...

  Eur Heart J 2017; DOI: 10.1093/eurheartj/ehx003] ... The authors wish to inform readers that the Conflict of Interest statement was incorrect as first published. The statement should have been ...

  Saturday, April 14th 2018

• 

  Rapidly getting resuscitation skills to the patient with out-of-hospital cardiac arrest

  It is well known that any cardio-pulmonary resuscitation (CPR) is better than none and that CPR acts as an effect modifier, increasing the likelihood of patients being found in a salvageable rhythm ...

  By Smith, Karen Sunday, April 1st 2018

• 

  Fibrin clot properties independently predict adverse clinical outcome following acute coronary ...

  Abstract Aims To determine whether fibrin clot properties are associated with clinical outcomes following acute coronary syndrome (ACS). Methods and results Plasma samples were collected at hospital ...

  By Sumaya, Wael Sunday, April 1st 2018

• 

  Today on ESC TV

  The latest from ESC Congress 2017. Follow live sessions, key messages, daily wrap-ups, plus insights and perspectives from world renowned experts Saturday 26 August 2017 CEST Session video Session ...

  Monday, March 26th 2018 at 3:24 PM

• 

  Cardiovascular Round Table - Industry Partners

  The Cardiovascular Round Table comprises 22 industry partners from across the pharmaceuticals, devices and equipment sectors. Amgen AstraZeneca Bayer Boehringer-Ingelheim Bristol-Myers Squibb ...

  Monday, March 26th 2018 at 1:14 PM

• 

  External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for ...

  Abstract Aims The aims of the present study were to describe the proportion of patients eligible for the COMPASS trial within the Reduction of Atherothrombosis for Continued Health (REACH) registry, ...

  By Darmon, Arthur Thursday, March 1st 2018

• 

  A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, ...

  Abstract Aims In atrial fibrillation (AF), mortality remains high despite effective anticoagulation. A model predicting the risk of death in these patients is currently not available. We developed ...

  By Hijazi, Ziad Wednesday, February 7th 2018

• 

  ESC Heart & Brain Workshop

  Watch webcasts Scientific programme by day & resources Resources are available by clicking on the title of the presentations. Friday 19 January 2018 Welcome by the Chairperson of the Council on ...

  Friday, January 19th 2018

• 

  The challenges of antithrombotic therapy in patients with left ventricular thrombosis

  Abstract This editorial refers to Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarctions by N. Maniwa et al., on page ...

  By Sumaya, Wael Sunday, January 14th 2018